SCHOTT Pharma AG & Co. KGaA (BIT:1SXP)

Market Cap	3.71B +13.4%
Revenue (ttm)	1.02B +4.2%
Net Income	136.22M -7.5%
EPS	0.90 -7.2%
Shares Out	n/a
PE Ratio	27.20
Forward PE	20.68
Dividend	0.18 (0.76%)
Ex-Dividend Date	Feb 4, 2026

Volume	n/a
Open	23.55
Previous Close	23.55
Day's Range	23.55 - 23.55
52-Week Range	13.18 - 24.30
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 10, 2026

About BIT:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold application...

• Industry: Glass Containers
• Founded: 1884
• Employees: 5,002
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1SXP

Financial Performance

In fiscal year 2025, BIT:1SXP's revenue was 986.21 million, an increase of 3.04% compared to the previous year's 957.09 million. Earnings were 146.45 million, a decrease of -2.16%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 25, 2026

Data Sources Report a data error